Belizatinib
目录号: A20919
ALK/TRKA/TRKB/TRKC 抑制剂
Belizatinib 是一种口服的、双重的、强效的 ALK 和 TRKA、TRKB、TRKC 抑制剂,对野生型重组 ALK 激酶的 IC50 为 0.7 nM。
| Discription | Belizatinib is an oral, dual, potent inhibitor of ALK and TRKA, TRKB, and TRKC, with IC50 of 0.7?nM for wild-type recombinant ALK kinase. | |||||
|---|---|---|---|---|---|---|
| Cell Research |
|
| 目录号 | A20919 |
|---|---|
| 分子式 | C33H44FN5O3 |
| 分子量 | 577.73 |
| CAS号 | 1357920-84-3 |
| SMILES | O=C(NC1=NC2=CC=C(CN3CCC(C(C)(O)C)CC3)C=C2N1[C@H]4CC[C@@H](C(NC(C)C)=O)CC4)C5=CC=C(F)C=C5 |
| 其他名称 | TSR 011, TSR011 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 96 mg/mL (166.17 mM) | |
| Water | Insoluble | ||
| Ethanol | 96 mg/mL (166.17 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 17.31 mL | 86.55 mL | 173.09 mL |
| 0.5 mM | 3.46 mL | 17.31 mL | 34.62 mL |
| 1 mM | 1.73 mL | 8.65 mL | 17.31 mL |
| 5 mM | 0.35 mL | 1.73 mL | 3.46 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2